scholarly journals The Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and its Soluble Form: Cardiovascular Implications

2010 ◽  
Vol 17 (4) ◽  
pp. 317-331 ◽  
Author(s):  
Teresa Navarra ◽  
Serena Del Turco ◽  
Sergio Berti ◽  
Giuseppina Basta
Keyword(s):  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Soluble Form ◽  
Low Density ◽  
Lipoprotein Receptor ◽  
Oxidized Low Density Lipoprotein ◽  
Low Density Lipoprotein Receptor ◽  
Density Lipoprotein Receptor

scholarly journals Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases

2013 ◽  
Vol 35 ◽  
pp. 413-418 ◽  
Author(s):  
Angela Pirillo ◽  
Alberico Luigi Catapano
Keyword(s):  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Coronary Intervention ◽  
Soluble Form ◽  
Low Density ◽  
Lipoprotein Receptor ◽  
Oxidized Low Density Lipoprotein ◽  
Low Density Lipoprotein Receptor ◽  
Coronary Syndrome ◽  
Density Lipoprotein Receptor

Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1), the main oxidized low-density lipoprotein (OxLDL) in endothelial cells, is upregulated in atherosclerotic lesions and is involved in several cellular processes that regulate the pathogenesis of atherosclerosis. The LOX-1 expressed on the cell surface can be proteolytically cleaved and released in a soluble form (sLOX-1) in the circulation under pathological conditions. Serum levels of sLOX-1, in fact, are elevated at the early stages of acute coronary syndrome and are associated with coronary plaque vulnerability and with the presence of multiple complex coronary lesions. Moreover, in subjects with stable CAD, levels of serum sLOX-1 are associated with the presence of lesions in the proximal and mid-segments of the left anterior descending artery that are the most prone to rupture; in subjects undergoing percutaneous coronary intervention, baseline preprocedural serum sLOX-1 levels are associated with the incidence of periprocedural myocardial infarction. Altogether, these findings suggest that circulating levels of sLOX-1 might be a diagnostic and prognostic marker for atherosclerotic-related events.

scholarly journals Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease

Circulation ◽  
2019 ◽  
Vol 139 (2) ◽  
pp. 243-255 ◽  
Author(s):  
Katerina Tsilingiri ◽  
Hortensia de la Fuente ◽  
Marta Relaño ◽  
Raquel Sánchez-Díaz ◽  
Cristina Rodríguez ◽  
...  
Keyword(s):  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Low Density ◽  
Lipoprotein Receptor ◽  
Oxidized Low Density Lipoprotein ◽  
Low Density Lipoprotein Receptor ◽  
Subclinical Disease ◽  
Density Lipoprotein Receptor
Sign in / Sign up

Export Citation Format

Share Document